Citadel Advisors LLC Has $668,000 Position in Safeguard Scientifics, Inc. (NYSE:SFE)

Citadel Advisors LLC grew its holdings in shares of Safeguard Scientifics, Inc. (NYSE:SFE) by 173.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 56,118 shares of the asset manager’s stock after purchasing an additional 35,609 shares during the period. Citadel Advisors LLC owned 0.27% of Safeguard Scientifics worth $668,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of SFE. KBC Group NV grew its position in Safeguard Scientifics by 47.5% in the 1st quarter. KBC Group NV now owns 9,447 shares of the asset manager’s stock valued at $120,000 after buying an additional 3,044 shares in the last quarter. American International Group Inc. grew its position in Safeguard Scientifics by 7.2% in the 1st quarter. American International Group Inc. now owns 12,407 shares of the asset manager’s stock valued at $158,000 after buying an additional 833 shares in the last quarter. Nationwide Fund Advisors grew its position in Safeguard Scientifics by 7.6% in the 2nd quarter. Nationwide Fund Advisors now owns 14,195 shares of the asset manager’s stock valued at $169,000 after buying an additional 1,006 shares in the last quarter. Alliancebernstein L.P. boosted its position in shares of Safeguard Scientifics by 27.4% during the 2nd quarter. Alliancebernstein L.P. now owns 14,430 shares of the asset manager’s stock valued at $172,000 after purchasing an additional 3,100 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in shares of Safeguard Scientifics by 12.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 15,336 shares of the asset manager’s stock valued at $195,000 after purchasing an additional 1,754 shares in the last quarter. 77.59% of the stock is currently owned by institutional investors.

Several equities analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of Safeguard Scientifics from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th. BidaskClub upgraded shares of Safeguard Scientifics from a “hold” rating to a “buy” rating in a report on Thursday, July 13th. Finally, ValuEngine upgraded shares of Safeguard Scientifics from a “strong sell” rating to a “sell” rating in a report on Friday, September 1st.

Shares of Safeguard Scientifics, Inc. (NYSE SFE) opened at 14.15 on Tuesday. Safeguard Scientifics, Inc. has a 52-week low of $10.60 and a 52-week high of $14.35. The stock’s market capitalization is $288.84 million. The stock has a 50 day moving average of $13.01 and a 200-day moving average of $12.17.

Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings data on Thursday, July 27th. The asset manager reported ($1.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.11) by ($0.32). During the same quarter in the prior year, the company posted $1.92 earnings per share. On average, equities research analysts predict that Safeguard Scientifics, Inc. will post ($3.49) EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This report was first reported by BBNS and is owned by of BBNS. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://baseballnewssource.com/markets/citadel-advisors-llc-purchases-35609-shares-of-safeguard-scientifics-inc-sfe/1698284.html.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Institutional Ownership by Quarter for Safeguard Scientifics (NYSE:SFE)

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Red Sox Waste Little Time in Firing John Farrell
Red Sox Waste Little Time in Firing John Farrell
Washington Nationals Sans Strasburg for Game 4 at Wrigley
Washington Nationals Sans Strasburg for Game 4 at Wrigley
Red Sox Beat Houston Sunday to Avoid Elimination
Red Sox Beat Houston Sunday to Avoid Elimination


Leave a Reply

 
© 2006-2017 BBNS.